抗PD-1疗法触发了Tfh细胞依赖的IL-4释放,以促进瘤排水淋巴结中的CD8T细胞反应
Mathilde Ruggiu1, Marion V Guérin1, Béatrice Corre1
1Institut Pasteur, Université de Paris Cité, INSERM U1223 , Paris, France.
The Journal of experimental medicine
|February 28, 2024
概括
抗PD-1疗法通过促进淋巴结中的T细胞反应来增强癌症免疫力. 这种免疫疗法刺激毛囊辅助T细胞 (Tfh) 产生IL-4,这是对周围抗癌活性的关键机制.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- T细胞研究的研究.
背景情况:
- 抗PD-1疗法对于癌症治疗至关重要,主要向CD8+ T细胞.
- 驱动抗PD-1疗法的外围机制的疗效仍然不完全理解.
研究的目的:
- 阐明抗PD-1疗法的外周活性背后的机制.
- 在抗PD-1治疗期间研究T细胞在瘤排水淋巴结 (TDLNs) 中的作用.
主要方法:
- 利用了两个不同的临床前癌症模型.
- 服用抗PD-1单克隆抗体 (mAb) 并评估TDLN中的T细胞激活和增殖.
- 研究了毛囊辅助T细胞 (Tfh) 和IL-4生产的作用.
- 使用IL-4阻断和BCL6抑制.
- 在人性化的小鼠模型中测试了IL-4复杂注射和尼沃卢马布.
主要成果:
- 抗PD-1 mAb增强了淋巴结内的瘤特异性T细胞激活和增殖.
- 抗PD-1 mAb的主要点被确定为Tfh细胞,而不是CD8+ T细胞.
- 抗PD-1 mAb治疗显著增加了Tfh细胞的IL-4产生.
- 阻断IL-4或抑制BCL6取消了抗PD-1mAb的淋巴结效应.
- 注射IL-4复合物模仿了抗PD-1 mAb的作用.
- 尼沃卢马布在人性化小鼠中对人类Tfh细胞表现出类似的效果.
结论:
- 毛囊辅助T细胞 (Tfh) 和它们的细胞因子IL-4是抗PD-1疗法的外周活性的关键调解者.
- 这项研究揭示了一种涉及Tfh细胞和IL-4的新机制,该机制有助于抗PD-1免疫治疗的整体疗效.
- 这些发现表明,在癌症治疗中,通过准Tfh-IL-4轴,可能有新的治疗策略.
相关概念视频
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
01:27Cytotoxic T Cells-mediated Immune Response
908
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
908
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:22T Cell Activation and Clonal Selection
731
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
731